Hudson Bay Capital Management

Investor type Hedge Fund


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
The average size of a deal this fund participated in
Portfolio companies 10
Rounds per year 0.65
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 6

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Life Science

The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Hudson Bay Capital Management, startups are often financed by PAG, OrbiMed, Janchor Partners. The meaningful sponsors for the fund in investment in the same round are PAG, China Venture Capital, Advantech Capital.

We also calculated 6 valuable employees in our database.

For fund there is no match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Alphamab Oncology. Among the most popular fund investment industries, there are Clinical Trials, Biotechnology.

The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Hudson Bay Capital Management:
Typical Co-investors
Hudson Bay Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Hudson Bay Capital Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Datiotec Electronics -
Highbridge Capital Management New York, New York, United States
Huimei Capital -
iSGS Investment Works Chiyoda, Japan
Ledstiernan Stockholm, Stockholm County, Sweden
National Cancer Research Institute England, London, United Kingdom
TASC Chantilly, United States, Virginia
The Hillman Group Cincinnati, Ohio, United States
Xandas New Media Ventures Italy, Lombardia, Milano

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Kyverna Therapeutics

Life Science
$85M26 Jan 2022 Berkeley, California, United States

WT Microtech Medical

$153M06 Oct 2021 Hangzhou, Zhejiang, China


Health Care
$75M29 Sep 2021 San Diego, California, United States

Carbon Health

Electronic Health Record (EHR)
Health Care
Mobile Apps
$350M21 Jul 2021 San Francisco, California, United States

CANbridge Pharmaceuticals

Health Care
$43M01 Dec 2020 Beijing

Harbour Biomed

$102M09 Jul 2020 Shanghai

Legend Biotech

Health Care
Life Science
$150M01 Apr 2020 New Jersey, United States


$100M17 Mar 2020 Huludao City, Liaoning, China

Rongchang Pharmaceutical

Health Care
16 Mar 2020 Huludao City, Liaoning, China
Scivita Medical Technology Receives RMB0.4 Billion in Series B Financing

– Scivita Medical Technology Co., Ltd. from Hong Kong is a maker of endoscopy products.
– The company received nearly RMB0.4 Billion in Series B financing.
– Backers included new investors such as Hudson Bay Capital Management and Prime Capital, as well as existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China.
– The new investment will be used for research and development, capacity expansion, and domestic and international commercialization of innovative products in endoscopy and related fields.

Carbon Health Secures $350 Million to Expand Omnichannel Primary Care Nationwide

– Carbon Health, a leading omnichannel healthcare provider, announced that it has raised $350m.
– The investment enables Carbon Health to further accelerate its expansion to become the largest primary care provider in the U.S. and fulfill its mission to make high-quality healthcare accessible to everyone.
– The round was led by Blackstone’s Horizon platform with participation from Atreides, Homebrew, Hudson Bay Capital, Intersect Capital, Fifth Wall, Lux Capital, Silver Lake Waterman, and funds and accounts managed by BlackRock.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Hudson Bay Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: